APYX News and Press, Apyx Medical Corporation From 07/18/22

RENUVION® CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECK PR Newswire Exclusive Apyx Medical Device Delivers State-Of-The-Art Plasma Energy To Improve Appearance of Loose Skin on The Neck and Ch...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration ...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that the results of the pivotal Phase II of its Investigational Device Exemp...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® and J-Plasma ® in surgical markets, today announced that financial results f...

Kezar Life Sciences (KZR) +93% after mid-stage data for lupus nephritis candidate. Agile Therapeutics (AGRX) +46%. Evofem Biosciences (EVFM) +33% collaboration for birth control method. InflaRx (IFRX) +17% on vilobelimab getting FDA orphan drug status for skin disorder. Ce...

RENUVION® DERMAL HANDPIECE FOR WRINKLE-REDUCTION PROCEDURES CLEARED BY FDA PR Newswire Revolutionary Apyx Medical Device Used by Top Physicians in the US Now Available to Patients for Nonsurgical Facial Renewal CLEARWATER, Fla. , June 28, 202...

New York, New York--(Newsfile Corp. - June 14, 2022) - Levi & Korsinsky, LLP notifies investors in Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX) of a class action securities lawsuit. The lawsuit on behalf of Apyx investors has been commenced in the the United States ...

Gainers: Apyx Medical (APYX) +39%. Enochian Biosciences (ENOB) +17%. Concert Pharmaceuticals (CNCE) +14%. GeoVax Labs (GOVX) +14%. Liquidia (LQDA) +13%. Losers: NRx Pharmaceuticals (NRXP) -57%. Avadel Pharmaceuticals (AVDL) -44%. Nurix Therape...

The shares of Apyx Medical (NASDAQ:APYX) added ~6% in the pre-market Thursday after the medical device maker announced that the FDA granted 510(k) clearance for the use of its Renuvion cosmetic technology in certain dermal resurfacing procedures. Accordingly, Renuvion is indicated for th...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® and J-Plasma ® in surgical markets, today announced it has received 510(k) c...